Clinical Trial Update: An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses [EARLY_Phase 1]

View source ↗

Summary

An open-label, long-term extension study evaluating the efficacy and safety of ustekinumab in patients with ichthyosis; the early-phase trial has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ichthyosis

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Northwestern University | Conditions: Ichthyosis | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-02-12